Berlin, Germany

Clemens Gunther

This inventor holds 2 USPTO granted patents. Top assignee: Schering Aktiengesellschaft. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Clemens Gunther. Retrieved from https://idiyas.com/inventor/clemens-gunther

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 151(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Clemens Gunther: Innovator in Transdermal Therapeutics

Introduction

Clemens Gunther is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of transdermal therapeutic systems, particularly in the area of sex steroids. With a total of 2 patents to his name, Gunther's work has the potential to impact the medical and pharmaceutical industries.

Latest Patents

Gunther's latest patents include innovative technologies such as transdermal therapeutic systems that contain sex steroids. Additionally, he has developed an agent for transdermal administration that contains gestodene esters. These inventions showcase his commitment to advancing therapeutic methods and improving patient care.

Career Highlights

Clemens Gunther is associated with Schering Aktiengesellschaft, a prominent company in the pharmaceutical sector. His work at this organization has allowed him to focus on developing cutting-edge solutions in transdermal delivery systems.

Collaborations

Throughout his career, Gunther has collaborated with esteemed colleagues such as Ralph Lipp and Jutta Riedl. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Clemens Gunther's contributions to transdermal therapeutics highlight his role as a key inventor in the field. His patents and collaborations reflect a dedication to advancing medical technology and improving therapeutic options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…